Start Over
Details View
SearchTitlesLibrary InformationOther DatabasesHelpHome


Collections of the National Library of Medicine
Search Request: Simple Search = 101465432
Search Results: Displaying 1 of 1 records

Holdings ViewDetailed ViewTable of ContentsMARC ViewMore Like This

Glycoproteomic analysis of HIV envelope proteins, with a focus towards...

Title: Glycoproteomic analysis of HIV envelope proteins, with a focus towards vaccine development [electronic resource] / Heather Desaire.
Variant Title: Title on PowerPoint: Glycoprotein analysis for AIDS vaccine development
Author(s)/Name(s): Desaire, Heather.
Publisher: [Bethesda, Md. : National Institutes of Health, 2008]
Related Names: National Institutes of Health (U.S.)
Language: eng
Electronic Links: http://videocast.nih.gov/launch.asp?14231
MeSH Subjects: AIDS Vaccines --immunology
Glycoproteins --immunology
Drug Design
Lectures
Summary: (CIT): The discovery of an effective vaccine is the best hope to conquer the HIV virus. While current methods in HIV vaccine development span a variety of strategies, one common method is using the virus’s own envelope glycoprotein as a vaccine candidate. This molecule is on the viral surface, and it provides the first contact between the virus and cells. Many glycoprotein vaccines are in development for the treatment of HIV, but none of them have passed the critical "efficacy" test in phase III clinical trials. My group hypothesizes that a major problem with the current candidates is the design and control of the carbohydrate portion of these glycoprotein vaccines, since this portion makes up 50% of the mass of the molecule, and very little is known about the "right" carbohydrates needed in the glycoprotein vaccine. We focus on analyzing these moieties using several mass spectrometric methods. By developing the appropriate methods to rapidly screen the carbohydrate content on glycoproteins, and applying these techniques to the glycoprotein on the surface of HIV, we hope to identify critical information needed to generate an effective vaccine against the world’s most illusive virus. This seminar will focus on our current successes and future goals in this endeavor.
Notes: Title from screen banner (viewed Feb. 29, 2008).
Streaming video (59 min. : sd., col.).
Mode of access: World Wide Web.
Open-captioned.
Terms of Use: Copyright: This is a work of the United States Government.
NLM Unique ID: 101465432
Other ID Numbers: (DNLM)CIT:14231


Options for Print, Save or E-mail
Select Download Format:
E-mail Full record(s) to:


SearchTitlesLibrary InformationOther DatabasesHelpHome

Copyright,Privacy,Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health,Health & Human Services
Contact NLM